Investigation of latent representation of toxicopathological images extracted by CNN model for understanding compound properties in vivo

Toxicopathological images acquired during safety assessment elucidate an individual’s biological responses to a given compound, and their numerization can yield valuable insights contributing to the assessment of compound properties. Currently, toxicopathological images are mainly encoded as pathological findings, evaluated by pathologists, which introduces challenges when used as input for modeling, specifically in terms of representation capability and comparability. In this study, we assessed the usefulness of latent representations extracted from toxicopathological images using Convolutional Neural Network (CNN) in estimating compound properties in vivo. Special emphasis was placed on examining the impact of learning pathological findings, the depth of frozen layers during learning, and the selection of the layer for latent representation. Our findings demonstrate that a machine learning model fed with the latent representation as input surpassed the performance of a model directly employing pathological findings as input, particularly in the classification of a compound’s Mechanism of Action and in predicting late-phase findings from early-phase images in repeated-dose tests. While learning pathological findings did improve accuracy, the magnitude of improvement was relatively modest. Similarly, the effect of freezing layers during learning was also limited. Notably, the selection of the layer for latent representation had a substantial impact on the accurate estimation of compound properties in vivo.

[1]  I. Zingman,et al.  Learning image representations for anomaly detection: application to discovery of histological alterations in drug development , 2022, Medical Image Anal..

[2]  S. Ishikawa,et al.  Universal encoding of pan-cancer histology by deep texture representations. , 2022, Cell reports.

[3]  M. Montalto,et al.  Digital pathology and artificial intelligence in translational medicine and clinical practice , 2021, Modern Pathology.

[4]  H. Kusuhara,et al.  Decomposition Profile Data Analysis for Deep Understanding of Multiple Effects of Natural Products. , 2021, Journal of natural products.

[5]  Yann LeCun,et al.  Barlow Twins: Self-Supervised Learning via Redundancy Reduction , 2021, ICML.

[6]  Oliver C. Turner,et al.  HistoNet: A Deep Learning-Based Model of Normal Histology , 2021, Toxicologic pathology.

[7]  Xinlei Chen,et al.  Exploring Simple Siamese Representation Learning , 2020, 2021 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR).

[8]  S. Gelly,et al.  An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale , 2020, ICLR.

[9]  Pavitra Krishnaswamy,et al.  Self-Path: Self-Supervision for Classification of Pathology Images With Limited Annotations , 2020, IEEE Transactions on Medical Imaging.

[10]  H. Kusuhara,et al.  Decomposition profile data analysis of multiple drug effects identifies endoplasmic reticulum stress-inducing ability as an unrecognized factor , 2020, Scientific Reports.

[11]  Pierre H. Richemond,et al.  Bootstrap Your Own Latent: A New Approach to Self-Supervised Learning , 2020, NeurIPS.

[12]  K. Plataniotis,et al.  How much off-the-shelf knowledge is transferable from natural images to pathology images? , 2020, PloS one.

[13]  Hamid R. Tizhoosh,et al.  Representation Learning of Histopathology Images using Graph Neural Networks , 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW).

[14]  Geoffrey E. Hinton,et al.  A Simple Framework for Contrastive Learning of Visual Representations , 2020, ICML.

[15]  Quoc V. Le,et al.  Self-Training With Noisy Student Improves ImageNet Classification , 2019, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR).

[16]  Quoc V. Le,et al.  EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks , 2019, ICML.

[17]  M. Gurcan,et al.  Digital pathology and artificial intelligence. , 2019, The Lancet. Oncology.

[18]  Richard Zhang,et al.  Making Convolutional Networks Shift-Invariant Again , 2019, ICML.

[19]  Jon Kleinberg,et al.  Transfusion: Understanding Transfer Learning for Medical Imaging , 2019, NeurIPS.

[20]  Raphaël Marée,et al.  Comparison of Deep Transfer Learning Strategies for Digital Pathology , 2018, 2018 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW).

[21]  Lukasz Kaiser,et al.  Attention is All you Need , 2017, NIPS.

[22]  Angela N. Brooks,et al.  A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles , 2017, Cell.

[23]  Qi Tian,et al.  SIFT Meets CNN: A Decade Survey of Instance Retrieval , 2016, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[24]  J. Aronson,et al.  Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature , 2016, BMC Medicine.

[25]  Jian Sun,et al.  Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[26]  Hiroshi Yamada,et al.  Open TG-GATEs: a large-scale toxicogenomics database , 2014, Nucleic Acids Res..

[27]  Qiang Chen,et al.  Network In Network , 2013, ICLR.

[28]  Pascal Vincent,et al.  Representation Learning: A Review and New Perspectives , 2012, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[29]  Fei-Fei Li,et al.  ImageNet: A large-scale hierarchical image database , 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition.

[30]  J. Kramer,et al.  The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates , 2007, Nature Reviews Drug Discovery.

[31]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[32]  David G. Lowe,et al.  Distinctive Image Features from Scale-Invariant Keypoints , 2004, International Journal of Computer Vision.

[33]  Ausif Mahmood,et al.  Recent Advances in Variational Autoencoders With Representation Learning for Biomedical Informatics: A Survey , 2021, IEEE Access.

[34]  S. Lipton Failures and successes of NMDA receptor antagonists: Molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults , 2011, NeuroRX.

[35]  Yoshua Bengio,et al.  Gradient-based learning applied to document recognition , 1998, Proc. IEEE.